Medication
Semaglutide usually reflects steadier progress. Tirzepatide often projects a faster pace. Retatrutide is investigational and research-only.
This version changes the projection based on semaglutide, tirzepatide, or investigational retatrutide. It uses a stronger early phase and a slower later phase so the estimate does not stay flat all year.
Calculator disclaimer: This tool provides educational estimates only and is not medical advice, diagnosis, or treatment. Individual outcomes vary.
Choose the medication first. That selection changes the engine behind the projections.
Quick guidance for choosing your inputs and interpreting your estimate with realistic expectations.
Semaglutide usually reflects steadier progress. Tirzepatide often projects a faster pace. Retatrutide is investigational and research-only.
This helps estimate how efficiently your body uses energy. Higher activity can slightly improve projected pace, and even light activity matters.
Protein helps protect muscle during weight loss. Better intake can support body composition and preserve lean mass while fat is reduced.
Hydration supports energy, digestion, and medication tolerance. Water intake can influence how people feel during a GLP-1 program.
Early weeks can be slower. Progress often changes as dosing increases over time, so this input helps make your estimate more realistic.
Results are estimates, not guarantees. You will see a range instead of a fixed promise, and milestones help map the likely path forward.
These inputs help create a more useful estimate, but real results depend on consistency, medication plan, and provider guidance.
This calculator gives an estimate only. It does not predict your actual result. Retatrutide is investigational and should not be shown as an approved treatment option. Final treatment choice, dosing, risk review, and follow-up belong with a licensed clinician.